Cargando…

NKG2D ligand RAE1ε induces generation and enhances the inhibitor function of myeloid‐derived suppressor cells in mice

Expression of surface NKG2D ligands on tumour cells, which activates nature killer (NK) cells and CD8(+) T cells, is crucial in antitumour immunity. Some types of tumours have evolved mechanisms to suppress NKG2D‐mediated immune cell activation, such as tumour‐derived soluble NKG2D ligands or sustai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qian, Li, Liu, Yang, Wang, Shaoqing, Gong, Weijuan, Jia, Xiaoqin, Liu, Lu, Ye, Feng, Ding, Jingjuan, Xu, Yuwei, Fu, Yi, Tian, Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571551/ https://www.ncbi.nlm.nih.gov/pubmed/28276625 http://dx.doi.org/10.1111/jcmm.13124

Ejemplares similares

The NKG2D Ligands RAE-1δ and RAE-1ε Differ with Respect to Their Receptor Affinity, Expression Profiles and Transcriptional Regulation
por: Cédile, Oriane, et al.
Publicado: (2010)

Chronic In Vivo Interaction of Dendritic Cells Expressing the Ligand Rae-1ε with NK Cells Impacts NKG2D Expression and Function
por: Morvan, Maelig G., et al.
Publicado: (2017)

Tumor-derived CSF-1 induces the NKG2D ligand RAE-1δ on tumor-infiltrating macrophages
por: Thompson, Thornton W, et al.
Publicado: (2018)

A Herpesviral induction of RAE-1 NKG2D ligand expression occurs through release of HDAC mediated repression
por: Greene, Trever T, et al.
Publicado: (2016)

RAE-1 ligands for the NKG2D receptor are regulated by E2F transcription factors, which control cell cycle entry
por: Jung, Heiyoun, et al.
Publicado: (2012)

Rae of the Arctic.
por: Richards, R L
Publicado: (1975)

Alexander Rae
Publicado: (1913)

Dr John Rae
por: Haigh, Elizabeth
Publicado: (1985)

William Murdoch Rae
Publicado: (1916)

James Donald Rae Monro
Publicado: (1941)

George Herbert Rae Gibson
Publicado: (1932)

Rae1 drives NKG2D binding‐dependent tumor development in mice by activating mTOR and STAT3 pathways in tumor cells
por: Zhao, Peiyan, et al.
Publicado: (2020)

The Dick and Rae physics demo notebook
por: Carpenter, D Rae, et al.
Publicado: (2003)

McRae, Traumatología : tratamiento de las fracturas en urgencias /
Publicado: (2017)

The Role and Regulation of the NKG2D/NKG2D Ligand System in Cancer
por: Tan, Ge, et al.
Publicado: (2023)

Tumor suppressors control ULBP2, an innate surface ligand of the lymphocyte immune receptor NKG2D
por: Heinemann, Anja, et al.
Publicado: (2012)

The Latest Breakthroughs in Immunotherapy for Acute Myeloid Leukemia, with a Special Focus on NKG2D Ligands
por: Maurer, Stefanie, et al.
Publicado: (2022)

NKG2D/NKG2-Ligand Pathway Offers New Opportunities in Cancer Treatment
por: Frazao, Alexandra, et al.
Publicado: (2019)

Cutting an NKG2D Ligand Short: Cellular Processing of the Peculiar Human NKG2D Ligand ULBP4
por: Zöller, Tobias, et al.
Publicado: (2018)

NKG2D(+)CD4(+) T Cells Kill Regulatory T Cells in a NKG2D-NKG2D Ligand- Dependent Manner in Systemic Lupus Erythematosus
por: Yang, Di, et al.
Publicado: (2017)

Secretory pathways generating immunosuppressive NKG2D ligands: New targets for therapeutic intervention
por: Baragaño Raneros, Aroa, et al.
Publicado: (2014)

Leveraging NKG2D Ligands in Immuno-Oncology
por: Fuertes, Mercedes Beatriz, et al.
Publicado: (2021)

The NKG2D/NKG2DL Axis in the Crosstalk Between Lymphoid and Myeloid Cells in Health and Disease
por: Stojanovic, Ana, et al.
Publicado: (2018)

ADAM10 new selective inhibitors reduce NKG2D ligand release sensitizing Hodgkin lymphoma cells to NKG2D-mediated killing
por: Zocchi, Maria Raffaella, et al.
Publicado: (2015)

Role of Polymorphisms of NKG2D Receptor and Its Ligands in Acute Myeloid Leukemia and Human Stem Cell Transplantation
por: Machuldova, Alena, et al.
Publicado: (2021)

How Mucosal Epithelia Deal with Stress: Role of NKG2D/NKG2D Ligands during Inflammation
por: Antonangeli, Fabrizio, et al.
Publicado: (2017)

Chitosan nanoparticle-based delivery of fused NKG2D–IL-21 gene suppresses colon cancer growth in mice
por: Tan, Lunmei, et al.
Publicado: (2017)

New twist on the regulation of NKG2D ligand expression
por: Cerwenka, Adelheid
Publicado: (2009)

New twist on the regulation of NKG2D ligand expression
por: Cerwenka, Adelheid
Publicado: (2009)

Molecular Bases for the Regulation of NKG2D Ligands in Cancer
por: Huergo-Zapico, Leticia, et al.
Publicado: (2014)

NKG2D ligands mediate immunosurveillance of senescent cells
por: Sagiv, Adi, et al.
Publicado: (2016)

NKG2D discriminates diverse ligands through selectively mechano‐regulated ligand conformational changes
por: Fan, Juan, et al.
Publicado: (2021)

Immune complex negatively regulates toll-like receptor 3-triggered tumour necrosis factor α production in B cells
por: Qian, Li, et al.
Publicado: (2017)

Fusion Proteins of NKG2D/NKG2DL in Cancer Immunotherapy
por: Ding, Hui, et al.
Publicado: (2018)

The Generation and Identity of Human Myeloid-Derived Suppressor Cells
por: Bergenfelz, Caroline, et al.
Publicado: (2020)

Generation of a monoclonal antibody against the glycosylphosphatidylinositol-linked protein Rae-1 using genetically engineered tumor cells
por: Hu, Jiemiao, et al.
Publicado: (2014)

Smoking induces expression of ligands of the immune receptor NKG2D
por: Ospelt, Caroline, et al.
Publicado: (2012)

NKG2D ligands link oncogenic RAS to innate immunity
por: Ho, Samantha S.W., et al.
Publicado: (2013)

NKG2D and Its Ligands: “One for All, All for One”
por: Zingoni, Alessandra, et al.
Publicado: (2018)

The NKG2D ligand ULBP4 is not expressed by human monocytes
por: Lazarova, Mariya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9vg8qbu0ckdfahl6bdu2b9g5ds